Trial · NCT01617096
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Efficacy as Determined by the Proportion of Women in Each Arm With HIV-1 Seroconversion After 120 Endpoints Are Observed in the Trial. | Dapivirine Vaginal Ring | 71 | Participants | ||
| Efficacy as Determined by the Proportion of Women in Each Arm With HIV-1 Seroconversion After 120 Endpoints Are Observed in the Trial. | Placebo Ring | 97 | Participants | ||
The Number of Participants That Experienced Grade 2, 3, 4 and Serious Adverse Events Over the Investigational Product Used Period (25 mg Dapivirine Administered in a Silicone Elastomer Vaginal Matrix Ring (DVR), Inserted Once Every 4 Weeks). | Dapivirine Vaginal Ring | 1237 | Participants | ||
The Number of Participants That Experienced Grade 2, 3, 4 and Serious Adverse Events Over the Investigational Product Used Period (25 mg Dapivirine Administered in a Silicone Elastomer Vaginal Matrix Ring (DVR), Inserted Once Every 4 Weeks). | Placebo Ring | 1231 | Participants | ||
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 1 | 443 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 2 | 460 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 3 | 953 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 4 | 537 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 5 | 573 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 6 | 963 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 7 | 687 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 8 | 699 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 9 | 943 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 10 | 830 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 11 | 916 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 12 | 922 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 13 | 872 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 14 | 858 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 15 | 793 | participants with data | |
| Adherence to the Dapivirine Vaginal Ring. | Dapivirine Vaginal Ring | Month 16 | 704 | participants with data |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01617096/results